| 000 | 02685 a2200637 4500 | ||
|---|---|---|---|
| 005 | 20250513230135.0 | ||
| 264 | 0 | _c20010215 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0892-6638 | ||
| 024 | 7 |
_a10.1096/fj.00-0247com _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMechtcheriakova, D | |
| 245 | 0 | 0 |
_aSpecificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. _h[electronic resource] |
| 260 |
_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cJan 2001 |
||
| 300 |
_a230-242 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 | _aEarly Growth Response Protein 1 |
| 650 | 0 | 4 |
_aEndothelial Growth Factors _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 | _aGenes, Dominant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aI-kappa B Kinase |
| 650 | 0 | 4 | _aImmediate-Early Proteins |
| 650 | 0 | 4 |
_aLymphokines _xpharmacology |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aReceptor Cross-Talk _xdrug effects |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Growth Factor _xmetabolism |
| 650 | 0 | 4 | _aReceptors, Vascular Endothelial Growth Factor |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 |
_aThromboplastin _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 | _aUmbilical Veins |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factors |
| 700 | 1 | _aSchabbauer, G | |
| 700 | 1 | _aLucerna, M | |
| 700 | 1 | _aClauss, M | |
| 700 | 1 | _aBinder, B R | |
| 700 | 1 | _aHofer, E | |
| 773 | 0 |
_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 15 _gno. 1 _gp. 230-242 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1096/fj.00-0247com _zAvailable from publisher's website |
| 999 |
_c11089754 _d11089754 |
||